Neoadjuvant androgen-deprivation therapy prior to radical prostatectomy: Con

被引：8
|
作者：
Paulson, DF
机构：
来源：
UROLOGY | 1996年 / 48卷 / 04期
关键词：
D O I：
10.1016/S0090-4295(96)00297-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [11] Neoadjuvant androgen deprivation prior to radical prostatectomy - A tool in successful surgical treatment of cancer of the prostrate
    Weber, A
    Kohrmann, KU
    Siegsmund, M
    Alken, P
    ONKOLOGIE, 1996, 19 (01): : 89 - 91
  • [12] Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy
    Liow, Elizabeth
    Howard, Nicholas
    Jung, Chol-Hee
    Pope, Bernard
    Campbell, Bethany K.
    Nguyen, Anne
    Kerger, Michael
    Ruddle, Jonathan B.
    Anton, Angelyn
    Thomas, Benjamin
    Chu, Kevin
    Dundee, Philip
    Peters, Justin S.
    Costello, Anthony J.
    Ryan, Andrew S.
    Hovens, Christopher M.
    Ben Tran
    Corcoran, Niall M.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : 452 - 458
  • [13] Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status
    Tyler R. McClintock
    Nicolas von Landenberg
    Alexander P. Cole
    Stuart R. Lipsitz
    Philipp Gild
    Maxine Sun
    Sean A. Fletcher
    Florian Roghmann
    Mani Menon
    Paul L. Nguyen
    Joachim Noldus
    Toni K. Choueiri
    Adam S. Kibel
    Quoc-Dien Trinh
    Annals of Surgical Oncology, 2019, 26 : 297 - 305
  • [14] Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status
    McClintock, Tyler R.
    von Landenberg, Nicolas
    Cole, Alexander P.
    Lipsitz, Stuart R.
    Gild, Philipp
    Sun, Maxine
    Fletcher, Sean A.
    Roghmann, Florian
    Menon, Mani
    Nguyen, Paul L.
    Noldus, Joachim
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (01) : 297 - 305
  • [15] NEOADJUVANT ANDROGEN DEPRIVATION THERAPY PRIOR TO RADICAL PROSTATECTOMY: RECENT TRENDS IN UTILIZATION AND ASSOCIATION WITH POSTOPERATIVE SURGICAL MARGIN STATUS
    von Landenberg, Nicolas
    Cole, Alexander P.
    McClintock, Tyler R.
    Fletcher, Sean A.
    Gild, Philipp
    Lipsitz, Stuart R.
    Sun, Maxine
    Abdollah, Firas
    Roghmann, Florian
    Menon, Mani
    Noldus, Joachim
    Kibel, Adam S.
    Trinh, Quoc-Dien
    JOURNAL OF UROLOGY, 2018, 199 (04): : E131 - E131
  • [16] NEOADJUVANT ANDROGEN DEPRIVATION THERAPY PRIOR TO RADICAL PROSTATECTOMY FOR LOCALLY VERY ADVANCED (CT4) PROSTATE CANCER
    Pompe, Raisa
    Hagen, Robert
    Mandel, Philipp
    Chun, Felix K.
    Gild, Philipp
    Steuber, Thomas
    Salomon, Georg
    Graefen, Markus
    Fisch, Margit
    Huland, Hartwig
    Tilki, Derya
    JOURNAL OF UROLOGY, 2019, 201 (04): : E963 - E963
  • [17] Neoadjuvant Androgen Deprivation Therapy Effects on Perioperative Outcomes Prior to Radical Prostatectomy: Eleven Years of Experiences at Ramathibodi Hospital
    Sangkum, Premsant
    Sirisopana, Kun
    Jenjitranant, Pocharapong
    Kijvikai, Kittinut
    Pacharatakul, Suthep
    Leenanupunth, Charoen
    Kochakarn, Wachira
    Kongchareonsombat, Wisoot
    RESEARCH AND REPORTS IN UROLOGY, 2021, 13 : 303 - 312
  • [18] Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy
    Kadono, Y.
    Nohara, T.
    Kawaguchi, S.
    Sakamoto, J.
    Makino, T.
    Nakashima, K.
    Iijima, M.
    Shigehara, K.
    Izumi, K.
    Mizokami, A.
    ANDROLOGY, 2018, 6 (06) : 903 - 908
  • [19] Neoadjuvant hormonal therapy prior to radical prostatectomy
    Civantos, F
    Sadek, S
    Obek, C
    Lai, SH
    Soloway, M
    MOLECULAR UROLOGY, 1999, 3 (03) : 201 - 204
  • [20] Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients
    Liu, Jinan
    Shi, Lizheng
    Sartor, Oliver
    Culbertson, Richard
    ONCOTARGETS AND THERAPY, 2013, 6 : 725 - 732
12345